This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs.
Nucleic acids research · 2026
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability.
PLoS genetics · 2022
Latest funding
- $1,124,550
eIF4A1-mediated translational regulation as a therapeutic vulnerability in metastatic uveal melanoma.
CIHR · 2026 · Nominated PI
- $9,000
Investigating the Role of the MNK1/2-eIF4E Signaling Axis by Spatially Profiling the Human Breast Cancer Tissue Tumor Microenvironment using Phenocycler (CODEX) -Fusion Technology
CIHR · 2026 · Supervisor
- $140,000
Understanding the immune mechanisms underlying skin immune-related adverse events in melanoma patients receiving immune checkpoint inhibitors
CIHR · 2025 · Supervisor
10 publications.
CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs.
Chaudhury A, Kongchan N, Massey SA, Sharma R, Pal R, Zhao N, Tsoi P, Zhu Y, Olokpa E, Mao S, Del Rincon S, Reineke LC, Lloyd RE, Sardiello M, Rosen JM, Kim C, Ferreon JC, Neilson JR
Phase Ib Pharmacodynamic Study of the MNK Inhibitor Tomivosertib (eFT508) Combined With Paclitaxel in Patients With Refractory Metastatic Breast Cancer.
Ferrario C, Mackey J, Gelmon KA, Levasseur N, Sorensen PH, Oo HZ, Negri GL, Tse VWL, Spencer SE, Cheng G, Morin GB, Del Rincon S, Cotechini T, Gonçalves C, Hindmarch CCT, Miller WH, Amiri M, Basiri T, Villareal-Corpuz V, Sperry S, Gregorczyk K, Spera G, Sonenberg N, Pollak M
Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability.
Simo Cheyou E, Boni J, Boulais J, Pinedo-Carpio E, Malina A, Sherill-Rofe D, Luo VM, Goncalves C, Bagci H, Maters A, Cuella-Martin R, Tabach Y, Del Rincon S, Côté JF, Rivera B, Orthwein A
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.
Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling.
Rys RN, Wever CM, Geoffrion D, Goncalves C, Ghassemian A, Brailovski E, Ryan J, Stoica L, Hébert J, Petrogiannis-Haliotis T, Dmitrienko S, Frenkiel S, Staiger A, Ott G, Steidl C, Scott DW, Sesques P, Del Rincon S, Mann KK, Letai A, Johnson NA
Cancer Plasticity: The Role of mRNA Translation.
Lee LJ, Papadopoli D, Jewer M, Del Rincon S, Topisirovic I, Lawrence MG, Postovit LM
Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis
Salituri J, Patey N, Takano T, Fiset P, Del Rincon S, Berkson L, Baron M, Hudson M, Baron M, Hudson M
CKS1 Germ Line Exclusion Is Essential for the Transition from Meiosis to Early Embryonic Development.
Ellederova Z, Del Rincon S, Koncicka M, Susor A, Kubelka M, Sun D, Spruck C
Oncogenic activity of poly (ADP-ribose) glycohydrolase.
Marques M, Jangal M, Wang LC, Kazanets A, da Silva SD, Zhao T, Lovato A, Yu H, Jie S, Del Rincon S, Mackey J, Damaraju S, Alaoui-Jamali M, Witcher M
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.
Zahreddine HA, Culjkovic-Kraljacic B, Emond A, Pettersson F, Midura R, Lauer M, Del Rincon S, Cali V, Assouline S, Miller WH, Hascall V, Borden KL
eIF4A1-mediated translational regulation as a therapeutic vulnerability in metastatic uveal melanoma.
Principal investigators: Del Rincon, Sonia V
Keywords: Liver Metastasis; Uveal Melanoma
Investigating the Role of the MNK1/2-eIF4E Signaling Axis by Spatially Profiling the Human Breast Cancer Tissue Tumor Microenvironment using Phenocycler (CODEX) -Fusion Technology
Principal investigators: McCallum, Paige
Keywords: Human Breast Cancer; Mnk1/2-Eif4e; Phenocycler; Tumor
Understanding the immune mechanisms underlying skin immune-related adverse events in melanoma patients receiving immune checkpoint inhibitors
Principal investigators: Valbon Fernandes Garcia, Stefanie
Keywords: Animal Models; Immune-Checkpoint Inhibitors; Immune-Related Adverse Events; Immunotherapy; Spatial Biology; T Cell Biology
Identifying the immune and stromal contributions underpinning skin toxicities from cancer immunotherapy.
Principal investigators: Del Rincon, Sonia V
Keywords: Cancer
Examining the role of the JAK-STAT pathway in ICI-arthritis and the effects of JAK inhibition on ICI in a novel tumor model of ICI-arthritis
Principal investigators: Papadopoulos, Theodoros
Keywords: Cancer; Cancer And Ici-Arthritis Mouse Modelling; Flow Cytometry; Immune Checkpoint Inhibitor-Arthritis; Immune Checkpoint Inhibitors; Immune Related Adverse Events; Jak-Stat; Proteomics - Somascan; Single Cell Rna Sequencing; Tofacitinib
Incretin-mimetic drugs for cancer prevention: Mechanisms and clinical potential
Principal investigators: Pollak, Michael N; Ammendolea, Cathy; Azoulay, Laurent; Muller, William J
Keywords: Biomarkers; Cancer Prevention; Mechanisms; Obesity; Pharmacoepidemiology; Semaglutide; Tirzepatide
Understanding the role of the MNK/eIF4E axis in cells of the tumor microenvironment to improve outcomes for patients with DLBCL.
Principal investigators: Del Rincon, Sonia V
Keywords: Cancer Biology; Extranodal Lymphoma; Immune Modulation; Mouse Models; Therapeutics
Investigating the Role of the MNK1/2-eIF4E Signaling Axis by Spatially Profiling the Human Breast Cancer Tissue Tumor Microenvironment using Phenocylcer (CODEX) Multiplex Imaging
Principal investigators: McCallum, Paige
Keywords: Cancer Associated Fibroblasts; Cancer Therapy; Cell Signaling; Machine Learning; Metastasis; Mrna Regulation; Multiplexed Imaging; Protein Expression; Spatial Biology; Tumor Microenvironment
Development of effective targeted anti-GD2 cancer immunotherapies, that synergize with immune-checkpoint inhibitor blockades
Principal investigators: Saragovi, Horacio U
Keywords: Adjuvant Therapy; Braf-Pten Mutation; Cancer Therapy; Combination Therapy; Gd2; Immune Checkpoint Inhibition; Melanoma; Monoclonal Antibody; Pd-1; Tumor Ganglioside
Exploring the therapeutic potential of combined inhibition of MNK1/2 and CDK4/6 to treat melanoma.
Principal investigators: Miller, Wilson H
Keywords: Immunotherapy; Kinase Inhibitors; Melanoma; Proteomics; Tumor Immune Microenvironment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Marie Hudson and Murray Baron: 134 shared papers
- Nader Khalidi and Margaret Larche: 89 shared papers
- Ivan Topisirovic and Ivan Topisirovic: 77 shared papers
- Nader Khalidi and Marie Hudson: 58 shared papers
- Nader Khalidi and Murray Baron: 56 shared papers
- Margaret Larche and Marie Hudson: 33 shared papers
- Margaret Larche and Murray Baron: 31 shared papers
- Nahum Sonenberg and Ivan Topisirovic: 25 shared papers
- Nahum Sonenberg and Ivan Topisirovic: 18 shared papers
- Lynne-Marie Postovit and Lynne-Marie Postovit: 14 shared papers
- Ivan Topisirovic and Michael Pollak: 12 shared papers
- Sonia Del Rincon and Sonia Del Rincon: 9 shared papers
- Michael Pollak and Ivan Topisirovic: 8 shared papers
- Nahum Sonenberg and Michael Pollak: 7 shared papers
- Ivan Topisirovic and Lynne-Marie Postovit: 5 shared papers
- Ivan Topisirovic and Lynne-Marie Postovit: 4 shared papers
- Michael Witcher and Ivan Topisirovic: 3 shared papers
- Michael Witcher and Ivan Topisirovic: 3 shared papers
- Michael Witcher and Moulay Alaoui-Jamali: 3 shared papers
- Lynne-Marie Postovit and Ivan Topisirovic: 3 shared papers
- Ivan Topisirovic and Lynne-Marie Postovit: 3 shared papers
- Michael Witcher and Sambasivarao Damaraju: 2 shared papers
- Michael Witcher and Alexandre Orthwein: 2 shared papers
- Tomoko Takano and Marie Hudson: 2 shared papers
- Nader Khalidi and Tomoko Takano: 1 shared paper
- Nader Khalidi and Sonia Del Rincon: 1 shared paper
- Nader Khalidi and Sonia Del Rincon: 1 shared paper
- Margaret Larche and Tomoko Takano: 1 shared paper
- Margaret Larche and Sonia Del Rincon: 1 shared paper
- Margaret Larche and Sonia Del Rincon: 1 shared paper
- Michael Witcher and Sonia Del Rincon: 1 shared paper
- Nahum Sonenberg and Sonia Del Rincon: 1 shared paper
- Nahum Sonenberg and Tiziana Cotechini: 1 shared paper
- Christian Steidl and Sonia Del Rincon: 1 shared paper
- Christian Steidl and Sonia Del Rincon: 1 shared paper
- Tomoko Takano and Sonia Del Rincon: 1 shared paper
- Wilson Miller and Marie Hudson: 1 shared paper
- Wilson Miller and Sonia Del Rincon: 1 shared paper
- Wilson Miller and Sonia Del Rincon: 1 shared paper
- Marie Hudson and Sonia Del Rincon: 1 shared paper
- Murray Baron and Sonia Del Rincon: 1 shared paper
- Sambasivarao Damaraju and Sonia Del Rincon: 1 shared paper
- Sambasivarao Damaraju and Moulay Alaoui-Jamali: 1 shared paper
- Alexandre Orthwein and Ivan Topisirovic: 1 shared paper
- Alexandre Orthwein and Sonia Del Rincon: 1 shared paper
- Alexandre Orthwein and Raquel Cuella Martin: 1 shared paper
- Ivan Topisirovic and Sonia Del Rincon: 1 shared paper
- Lynne-Marie Postovit and Sonia Del Rincon: 1 shared paper
- Lynne-Marie Postovit and Moulay Alaoui-Jamali: 1 shared paper
- Michael Pollak and Sonia Del Rincon: 1 shared paper
- Michael Pollak and Tiziana Cotechini: 1 shared paper
- Sonia Del Rincon and Ivan Topisirovic: 1 shared paper
- Sonia Del Rincon and Lynne-Marie Postovit: 1 shared paper
- Sonia Del Rincon and Moulay Alaoui-Jamali: 1 shared paper
- Sonia Del Rincon and Tiziana Cotechini: 1 shared paper
- Sonia Del Rincon and Raquel Cuella Martin: 1 shared paper
- Sonia Del Rincon and Raquel Cuella Martin: 1 shared paper
- Oncology
- Lady Davis Institute for Medical Research
- Biomedical and Molecular Sciences
- Medicine
- Experimental Therapeutics
- Psychiatry
- Rheumatology
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Sonia Del Rincon
Faculty
9 shared papers, latest 2026
Ivan Topisirovic
Faculty
1 shared papers, latest 2021
Lynne-Marie Postovit
Biomedical and Molecular Sciences
1 shared papers, latest 2021
Moulay Alaoui-Jamali
Faculty
1 shared papers, latest 2019
Tiziana Cotechini
Biomedical and Molecular Sciences
1 shared papers, latest 2025
Raquel Cuella Martin
Human Genetics
1 shared papers, latest 2022
Nader Khalidi
Medicine
1 shared papers, latest 2020
Margaret Larche
Medicine
1 shared papers, latest 2020
Michael Witcher
Oncology
1 shared papers, latest 2019
Nahum Sonenberg
Biochemistry
1 shared papers, latest 2025
Christian Steidl
Experimental Therapeutics
1 shared papers, latest 2021
Tomoko Takano
Medicine/Nephrology
1 shared papers, latest 2020
Wilson Miller
Lady Davis Institute for Medical Research
1 shared papers, latest 2021
Marie Hudson
Psychiatry
1 shared papers, latest 2020
Murray Baron
Rheumatology
1 shared papers, latest 2020
Sambasivarao Damaraju
Laboratory Medicine and Pathology
1 shared papers, latest 2019
Alexandre Orthwein
Faculty
1 shared papers, latest 2022
Ivan Topisirovic
Lady Davis Institute for Medical Research
1 shared papers, latest 2021
Lynne-Marie Postovit
Oncology
1 shared papers, latest 2021
Michael Pollak
Oncology
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.